IDH2 and astrocytoma (excluding glioblastoma): Detection of an IDH mutation in a diffuse astrocytic glioma with microvascular proliferation or necrosis is no longer compatible with a glioblastoma diagnosis, i.e., such tumors are now diagnosed as astrocytoma, IDH-mutant, CNS WHO grade 4 [7, 30].